I look at the chief talent scout from Princeton. A 27 year old telling a veteran successful rep about how to launch a drug, and that relationships aren’t important, especially during COVID where access is minimal. Doctors really need to hear about the 20th oab med on the market . And according to her, they want to know about it. Grow up, get educated. Oncology and saving lives is important. Before Pharmacia hit the market and built oab awareness, nobody cared and oxybutnin or Depends adult pads for you were fine. Nobody dies from oab, it’s a quality of life drug. You need to find an angle and reason why this drug needs to part of their prescribing treatment.
This is something that a tool like Barry doesn’t get. Try something néw! Think! What an old concept. Especially in this “sheep” environment.